Showing results (131-140 of 566) with videos related to
Sort By:
Pageof 57
Onkologie|April 1, 1986
[Clinical relevance of immune phenotyping of malignant lymphomas]V Diehl, M Schaadt, M PfreundschuhHematological Oncology|September 2, 1998
Hodgkin's disease biology: recent advancesA Jox, J Wolf, V DiehlThe Journal of Infection|July 1, 1997
Paradoxical expansion of intracranial tuberculomas during chemotherapyM Reiser, G Fätkenheuer, V DiehlAnnals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Male gonadal dysfunction in patients with Hodgkin's disease prior to treatmentU Rueffer, K Breuer, A Josting, et al.Leukemia & Lymphoma|February 1, 1997
A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin's lymphomaA Engert, R Schnell, F Küpper, et al.Current Topics in Microbiology and Immunology|July 22, 1998
The emerging role of ricin A-chain immunotoxins in leukemia and lymphomaA Engert, E A Sausville, E VitettaAnnals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2006
Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study GroupB Klimm, H T Eich, H Haverkamp, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 2005
Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG)L Nogová, T Reineke, H T Eich, et al.Medizinische Klinik (Munich, Germany : 1983)|January 5, 2002
[Artificial sweeteners--are they potentially carcinogenic?]M R Weihrauch, V Diehl, H BohlenHistology and Histopathology|March 1, 2005
Standardization of bone marrow features--does it work in hematopathology for histological discrimination of different disease patterns?J Thiele, H M Kvasnicka, V DiehlPageof 57